Literature DB >> 9933255

Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth.

R K Dubey1, Y Y Tyurina, V A Tyurin, D G Gillespie, R A Branch, E K Jackson, V E Kagan.   

Abstract

The goal of this study was to test the hypothesis that antioxidant estrogens, by a mechanism independent of the estrogen receptor, protect phospholipids residing in the plasma membrane of vascular smooth muscle cells from peroxidation and peroxidation-induced cell growth and migration. Peroxidation of membrane phospholipids was assessed by HPLC analysis of phospholipids extracted from rat aortic vascular smooth muscle cells prelabeled with cis-parinaric acid (a fatty acid that is susceptible to peroxidation, which quenches its fluorescent properties). Incubation of cells for 2 hours with the peroxyl radical donor 2,2'-azobis-2,4-dimethylvaleronitrile (AMVN) caused peroxidation of all measured membrane phospholipids. This effect was attenuated by pretreating cells for 15 minutes with 50 to 5000 ng/mL of 2-hydroxyestradiol (strong antioxidant but weak estrogen-receptor ligand) or 4-hydroxytamoxifen (strong antioxidant and potent estrogen-receptor ligand), but not by estrone or droloxifene (both weak antioxidants but potent estrogen-receptor ligands). Moreover, pretreatment of cells for 20 hours with physiological concentrations (0.3 ng/mL) of 2-hydroxyestradiol or pharmacologically relevant concentrations of 4-hydroxytamoxifen (40 ng/mL) also decreased AMVN-induced phospholipid peroxidation. Both 2-hydroxyestradiol and 4-hydroxytamoxifen were as effective as 2,2,5, 7,8-pentamethyl-6-hydrochromane (an antioxidant homolog of vitamin E) in attenuating AMVN-induced peroxidation of membrane phospholipids. Also, physiological concentrations of 2-hydroxyestradiol, but not estrone, and pharmacologically relevant concentrations of 4-hydroxytamoxifen attenuated AMVM-induced DNA synthesis, cell proliferation, and cell migration. These studies demonstrate in vascular smooth muscle cells that antioxidant estrogens via a non-estrogen receptor-dependent mechanism attenuate peroxidation of membrane phospholipids and peroxidation-induced cell growth and migration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933255     DOI: 10.1161/01.res.84.2.229

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  14 in total

Review 1.  Oxidative mechanisms and tardive dyskinesia.

Authors:  James B Lohr; Ronald Kuczenski; Alexander B Niculescu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

3.  Modulation of gene expression by Polyalthia longifolia in postmenopausal women with coronary artery disease: an in vitro study.

Authors:  Anupam Mittal; Nitin Mahajan; Rajesh Vijayvergiya; Veena Dhawan
Journal:  J Cardiovasc Transl Res       Date:  2009-12-30       Impact factor: 4.132

4.  Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.

Authors:  Yonghua Zhang; Dejan Milatovic; Michael Aschner; Paul J Feustel; Harold K Kimelberg
Journal:  Exp Neurol       Date:  2007-01-24       Impact factor: 5.330

5.  2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male Mice.

Authors:  Ajeeth K Pingili; Karen N Davidge; Shyamala Thirunavukkarasu; Nayaab S Khan; Akemi Katsurada; Dewan S A Majid; Frank J Gonzalez; L Gabriel Navar; Kafait U Malik
Journal:  Hypertension       Date:  2017-04-17       Impact factor: 10.190

6.  Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat.

Authors:  Alison Y Ting; Brian K Petroff
Journal:  J Assist Reprod Genet       Date:  2010-08-14       Impact factor: 3.412

Review 7.  Potential vascular actions of 2-methoxyestradiol.

Authors:  Raghvendra K Dubey; Edwin K Jackson
Journal:  Trends Endocrinol Metab       Date:  2009-09-04       Impact factor: 12.015

8.  Endogenous Estrogen-Mediated Heme Oxygenase Regulation in Experimental Menopause.

Authors:  Anikó Pósa; Renáta Szabó; Anett Csonka; Médea Veszelka; Anikó Magyariné Berkó; Zoltán Baráth; Rudolf Ménesi; Imre Pávó; Mariann Gyöngyösi; Ferenc László; Krisztina Kupai; Csaba Varga
Journal:  Oxid Med Cell Longev       Date:  2015-05-06       Impact factor: 6.543

Review 9.  Cancer morbidity in rheumatoid arthritis: role of estrogen metabolites.

Authors:  Wahid Ali Khan; Mohd Wajid Ali Khan
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

10.  Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.

Authors:  Anna R Hemnes; David G Kiely; Barbara A Cockrill; Zeenat Safdar; Victoria J Wilson; Manal Al Hazmi; Ioana R Preston; Mandy R MacLean; Tim Lahm
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.